The Value of Placebos to Individualize Pain Therapy via A New Singleblind Test Paradigm Identifying Responders on Topical Analgesic Interventions
Received Date: Mar 12, 2018 / Accepted Date: Mar 19, 2018 / Published Date: Mar 29, 2018
Pain management should be individualized for each patient as much as possible, and the use of a placebo in the clinical practice can help. The treatment with compounded topical analgesics holds a great promise for such individualized therapy, due to the fast response of patients after applying cream containing adequate concentrations of an active pharmaceutical ingredient. We present and discuss a new single-blinded placebo-controlled test paradigm, enabling the physician to quickly differentiate between responders and non-responders, and to further explore the concentration-effect response. This way the placebo assists in selecting the optimal pain treatment, and such use should be regarded as beneficial for patients and ethical correct.
Keywords: Ethics; Analgesia; Topicals; Phenytoin; Amitriptyline; Analgesic cream
Citation: Hesselink JMK, Kopsky DJ (2018) The Value of Placebos to Individualize Pain Therapy via A New Single-blind Test Paradigm Identifying Responders on Topical Analgesic Interventions. J Pain Relief 7: 313. Doi: 10.4172/2167-0846.1000313
Copyright: © 2018 Hesselink JMK, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Select your language of interest to view the total content in your interested language
Share This Article
Open Access Journals
- Total views: 3884
- [From(publication date): 0-2018 - Feb 04, 2023]
- Breakdown by view type
- HTML page views: 3228
- PDF downloads: 656